Awakening Caspase-2: Revitalizing the Cure for Dementia & Metabolic Diseases
Available Now: Geniunely selective Tools for Caspase 2 Research
IPCURE sets the only commercially available Caspase-2 selective inhibitor and fluorogenic probe enabling comprehensive investigation of Caspase-2 function across biological systems.
Our Mission
Developing drugs that selectively target individual caspases for the treatment of dementia and inflammatory diseases.
About Frontotemporal Dementia & Our Updates
-
![Best Wishes for 2026!]()
Happy New Year!
To patients, families, caregivers, partners & collaborators,
Your trust and commitment give meaning to our work and inspire us to move forward, together.
-
!['Global Destination for Opportunities']()
EWC - BIBAN 2025, Riyadh, KSA
Beyond recognition, BIBAN 2025 was marked by a warm welcome, a deep respect for cultural diversity, and meaningful human encounters.
-
![A person with short hair standing in a hedge maze, viewed from behind in black and white.]()
Frontotemporal Disease
Frontotemporal dementia (FTD) encompasses a range of brain disorders that primarily impact the frontal and temporal lobes, which are crucial for regulating personality, behavior, and language.
-
![Close-up of an elderly woman's eye and facial wrinkles, with a background of blurred greenery.]()
The primary symptoms of frontotemporal dementia (...)
The primary symptoms of frontotemporal dementia are marked by profound shifts in behavior and personality. These changes typically encompass (...)
-
![Event poster for Venture Summit West 2025 showcasing a crowd of business professionals at the Computer History Museum in Silicon Valley, CA, scheduled for April 2nd and 3rd.]()
VSW 2025, San Francisco, CA
IPCURE is proud to announce that it has been selected to present at the upcoming Venture Summit West, taking place on April 2nd & 3rd, 2025 at the Computer History Museum in Silicon Valley. Organized by youngStartup Ventures, the summit is the region's premier event for connecting the most promising startups with the venture capital, corporate venture, and angel investor communities.
Partners
